Study suggests gene variant CLU and CR1 associated with Alzheimer’s disease
Sunday 06 September 2009
Findings from a recent study on some 2,000 people with Alzheimer’s disease in France and over 5,000 controls, as well as nearly 4,000 people with Alzheimer’s disease and over 3,000 controls from other European countries, suggest that the genetic variants clusterin (CLU) and Erythrocyte complement receptor 1 (CR1) may be associated with Alzheimer’s disease.
The research was conducted by scientists from France, Italy, Spain, Belgium, Finland and Australia and published in the journal Nature Genetics
For further information please see:
and the journal Nature Genetics at: